Dexcom | DXCM - Equity Capital And Reserves

Stock Price
70.44
Daily Change
-0.38 -0.54%
Monthly
0.79%
Yearly
-20.24%
Q1 Forecast
70.79

Dexcom reported $2.73B in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Abbott USD 50.83B 0 Sep/2025
Align Technology USD 3.96B 44.68M Sep/2025
AtriCure USD 476.51M 12.02M Sep/2025
Avanos Medical USD 778M 1.7M Sep/2025
Baxter International USD 7.24B 79M Sep/2025
Becton, Dickinson and Co. USD 25.39B 82M Sep/2025
Boston Scientific USD 22.65B 235M Sep/2025
Cooper Companies USD 8.35B 64.9M Jun/2025
Dexcom USD 2.73B 153M Sep/2025
Edwards Lifesciences USD 10.2B 340.3M Sep/2025
Globus Medical USD 4.4B 103.14M Sep/2025
Hologic USD 5.25B 197.2M Dec/2025
Insulet USD 1.38B 78.8M Sep/2025
Integra LifeSciences USD 1.04B 1.09M Sep/2025
J&J USD 78.47B 0 Sep/2025
Masimo USD 810M 232.8M Sep/2025
Medtronic USD 47.89B 131M Jun/2025
Merit Medical Systems USD 1.53B 41.36M Sep/2025
Roche Holding CHF 33.8B 758M Dec/2025
Solventum Corp USD 4.99B 1.34B Sep/2025
Stryker USD 21.78B 594M Sep/2025
Tandem Diabetes Care USD 132.96M 318K Sep/2025
Teleflex USD 3.82B 421M Sep/2025
West Pharmaceutical Services USD 3.05B 122.4M Sep/2025
Zimmer Biomet Holdings USD 12.77B 231.7M Sep/2025